Tanvex BioPharma (TPE:6541) Receivables Turnover : 2.02 (As of Mar. 2025)

View and export this data going back to 2015. Start your Free Trial

What is Tanvex BioPharma Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Tanvex BioPharma's Revenue for the three months ended in Mar. 2025 was NT$49.86 Mil. Tanvex BioPharma's average Accounts Receivable for the three months ended in Mar. 2025 was NT$24.64 Mil. Hence, Tanvex BioPharma's Receivables Turnover for the three months ended in Mar. 2025 was 2.02.

Tanvex BioPharma Receivables Turnover Historical Data

The historical data trend for Tanvex BioPharma's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tanvex BioPharma Receivables Turnover Chart

Tanvex BioPharma Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Receivables Turnover

Get a 7-Day Free Trial

67.28

12.62

7.33

Tanvex BioPharma Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Receivables Turnover	Get a 7-Day Free Trial															0.42	1.39	0.98	0.99	2.02

Competitive Comparison of Tanvex BioPharma's Receivables Turnover

For the Biotechnology subindustry, Tanvex BioPharma's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tanvex BioPharma's Receivables Turnover Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Tanvex BioPharma's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Tanvex BioPharma's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Tanvex BioPharma Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Tanvex BioPharma's Receivables Turnover for the fiscal year that ended in Dec. 2024 is calculated as

	Receivables Turnover (A: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Dec. 2024 )	/ (	(Accounts Receivable (A: Dec. 2023 )	+	Accounts Receivable (A: Dec. 2024 ))	/	count )
=	34.678	/ (	(9.396	+	0.07)	/	2 )
=	34.678	/	4.733
=	7.33

Tanvex BioPharma's Receivables Turnover for the quarter that ended in Mar. 2025 is calculated as

	Receivables Turnover (Q: Mar. 2025 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Mar. 2025 )	/ (	(Accounts Receivable (Q: Dec. 2024 )	+	Accounts Receivable (Q: Mar. 2025 ))	/	count )
=	49.862	/ (	(0.07	+	49.21)	/	2 )
=	49.862	/	24.64
=	2.02

Tanvex BioPharma (TPE:6541) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Tanvex BioPharma Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Tanvex BioPharma's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Tanvex BioPharma Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Tanvex BioPharma Inc (TPE:6541) » Definitions » Receivables Turnover

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 376, Ren\'ai Road, Section 4, 13th Floor-1, Da\'an District, Taipei, TWN, 106

Website

https://www.tanvex.com

Tanvex BioPharma Inc is a biopharmaceutical company. It is engaged in the research, development, manufacture, and sale of biosimilar products and contract development and manufacturing of biological medicine. The company's products are used to cure diseases such as Neutropenia, Breast Cancer, Metastatic Colorectal Cancer, and others. Geographically, the company generates a majority of its revenue from Taiwan and the rest from the United States.

Tanvex BioPharma Headlines

No Headlines